TNF and rheumatoid arthritis: The resounding success of the anti-TNF and anti-IL-6 therapies for conditions such as Rheumatoid arthritis (RA) (3, 4) and SLE (5), respectively, has caused renewed interest in understanding how, why and when these potent molecules are secreted in health and disease.